Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.03.21.644674

The Photoswitchable Cannabinoid Azo-HU308 Enables Optical Control of Ca2+ Signaling in Pancreatic β-Cells via a Non CB2 TRPC Channel Mechanism

Viray, A. E.·Frank, J. A.
View original source ↗Export metadata ↓

Abstract

Background and PurposeCa2+ plays a critical role in regulating insulin secretion from pancreatic {beta}-cells, a process modulated by various cell surface receptors, including cannabinoid receptors (CBRs). However, our understanding of cannabinoid signaling in {beta}-cells is complicated by the intricate pharmacology of cannabinoid ligands and their inherent hydrophobicity, which hinders precise control of receptor activation. This study aims to investigate the effects of the light-activatable CB2 receptor agonist, azo-HU308, on {beta}-cell Ca2+ dynamics. Experimental ApproachWe employ fluorescent Ca2+ imaging in INS-1 832/13 (INS-1) {beta}-cells to measure Ca2+ transients induced by azo-HU308 and photoactivation with UV-A light. We then apply a pharmacological screen using a various CBR and TRP channel antagonists to determine the mechanism by which azo-HU308 enables optical control of {beta}-cell Ca2+ levels. Key ResultsWe observed that azo-HU308 triggers a robust increase in intracellular Ca2+ when isomerized to the cis-form with UV-A light. The effect was repeatable over multiple cycles of irradiation and gradually desensitized on each sequential UV-light pulse. A pharmacological screen determined that the Ca2+ increase was not due to CB2 receptor activation and Ca2+ release from intracellular stores, but rather influx of extracellular Ca2+ through TRPC channels. Conclusions and Implicationsazo-HU308 enables robust, repeatable stimulation of Ca2+ in INS-1 pancreatic {beta}-cells when triggered by UV-A light. This study presents a novel tool to optically control {beta}-cell Ca2+ dynamics, and sheds light on a new mechanism by which synthetic cannabinoids affect Ca2+ signaling through non-GPCR targets.

Explore related subjects

physiologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Viray, A. E., Frank, J. A.. 2025-03-25. The Photoswitchable Cannabinoid Azo-HU308 Enables Optical Control of Ca2+ Signaling in Pancreatic β-Cells via a Non CB2 TRPC Channel Mechanism. https://doi.org/10.1101/2025.03.21.644674

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Hypothalamic Farnesoid X Receptor deficiency alters energy balance by modulating hepatic glucose production and adipose tissue metabolism through central insulin signaling.

Objectives: The bile acid nuclear receptor Farnesoid X Receptor (FXR, NR1H4) is a major regulator of metabolism and energy homeostasis in peripheral organs. It modulates bile acid, glucose, and lipid metabolism, as well as fat mass and body weight. However, FXR is also expressed in the brain, particularly in the hypothalamus, a key center for the regulation of energy homeostasis. Although one study has demonstrated a role for brain FXR activation in energy balance, its specific hypothalamic role is still unknown. Here, we examined the role of FXR in the mediobasal hypothalamus in the regulation of energy balance. Methods: We used a genetic approach combined with metabolic phenotyping to determine the effect of FXR invalidation in the mediobasal hypothalamus on metabolic parameters involved in the central regulation of energy homeostasis. Results: Our results demonstrate that hypothalamic FXR deficiency induces a positive energy balance, resulting in a reduction in energy expenditure due to alterations in glucose metabolism accompanied by structural changes in white adipose tissues. Conclusion: This study uncovers a previously unrecognized role for hypothalamic FXR in the central homeostatic control of energy balance, providing new insights into its contribution to peripheral glucose metabolism and adipose tissue structural remodeling.

physiology↗
bioRxiv2026

Rad and Phospholamban are Key Drivers of the Ventricular Adrenergic Response and Stress-Induced Arrhythmia

The adrenergic response is a fundamental mechanism that regulates heart rate (chronotropy), cardiac contractility (inotropy) and relaxation (lusitropy). Adrenergic stress is also a recognized trigger of arrhythmia in disease. Yet, our understanding of the underlying molecular basis remains incomplete. Protein kinase A (PKA) and the calcium/calmodulin-dependent kinase II (CaMKII) phosphorylate multiple targets proposed to participate in the adrenergic response, including the GTP-binding protein Rad, phospholamban (PLB) and ryanodine receptor 2 (RyR2). Here we demonstrate that phosphorylation of both Rad and PLB is necessary for inotropy and lusitropy. We show that changes in cardiac contractility and relaxation are primarily dependent on intracellular calcium handling. Finally, we report that Rad and PLB control stress-induced arrhythmogenesis, despite the phosphorylation of other pro-arrhythmic targets. We have identified the essential molecular components of the adrenergic response, resolving a long-standing debate in cardiac excitation-contraction coupling and refining current models of sympathetic regulation in health and disease.

physiology↗
bioRxiv2026

Light-cycle time-restricted feeding remodels a hidden layer of the cardiac transcriptome through sex-specific transcript switching

Light-cycle time-restricted feeding disrupts daily cardiovascular and thermoregulatory rhythms, but the molecular effects of light-cycle time-restricted feeding on the heart have been measured only at the level of total gene expression. We used Oxford Nanopore long-read RNA sequencing to resolve the full-length ventricular transcriptome from male and female mice under ad libitum feeding or light-cycle time-restricted feeding across the 24-hour cycle. Greater than 20% of cardiac transcripts represent unannotated variants of known genes absent from the current GENCODE reference annotation. Light-cycle time-restricted feeding reorganizes transcript usage across hundreds of genes, including genes encoding splicing regulators, largely without changing total gene expression. The genes affected are sex-specific, with fewer than 2% of changes shared at the gene, transcript, and transcript-usage levels. We show that transcript-level regulation is a previously underrecognized component of the cardiac response to altered feeding behavior, undetected by conventional short-read approaches.

physiology↗